title: Professionally applied and prescribed fluoride products.
abstract: The US regulatory process relative to the marketing of sodium fluoride dietary supplements and professionally applied topical fluorides is examined with regard to interactions of ADA, NIH, academia, and the FDA, as well as resultant effects on industry, practitioners, and patients. Restrictions on noncaries use of fluoride limit commercial claims, but not professional practice. Prenatal fluoride supplements are still unapproved. Finally, the effects of generic competition and the regulatory process on costs, sales, quality of professional fluoride products and on new product research are discussed.
authors.affiliation: Colgate-Hoyt Laboratories, Sarasota, FL 34238.
authors.forename: M G
authors.initials: MG
authors.lastname: Grodberg
mesh_terms: D000571:American Dental Association; D017277:Drug Approval; D011307:Drug Prescriptions; D004335:Drug and Narcotic Control; D005460:Fluorides, Topical / Q000627:therapeutic use*; D006801:Humans; D012106:Research; D012969:Sodium Fluoride / Q000627:therapeutic use*; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D005460:Fluorides, Topical; D012969:Sodium Fluoride